Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

FDA Advisory Committee votes on Emsam

Oct. 31, 2005

SNT-MC17 begins phase IIa study for Duchenne muscular dystrophy

Oct. 31, 2005

Gantacurium induces mild histamine release in healthy volunteers

Oct. 31, 2005

Spotlight on sodium channel Nav1.8 in pain

Oct. 31, 2005

p53 inhibitor demonstrates neuroprotection in vivo

Oct. 31, 2005

Targeting p38 MAP kinase attenuates LA-mediated neurotoxicity and nerve injury evoked pain

Oct. 31, 2005

Studies highlight antidepressant efficacy and other benefits of agomelatine

Oct. 28, 2005

Encouraging results for QR-442 in multiple sclerosis mouse model

Oct. 28, 2005

Cerimon acquires U.S. rights to topical diclofenac formulations

Oct. 28, 2005

Further evidence that TRPV1 antagonism alleviates bone cancer pain

Oct. 28, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026